EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,004,000 | +1.2% | 200,000 | 0.0% | 0.26% | -23.8% |
| Q2 2022 | $1,980,000 | +0.6% | 200,000 | 0.0% | 0.34% | +63.9% |
| Q1 2022 | $1,968,000 | +0.8% | 200,000 | 0.0% | 0.20% | -8.5% |
| Q4 2021 | $1,952,000 | -0.2% | 200,000 | 0.0% | 0.22% | -5.9% |
| Q3 2021 | $1,956,000 | -0.7% | 200,000 | 0.0% | 0.24% | +4.4% |
| Q2 2021 | $1,969,000 | – | 200,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|